Dr Miranda Payne

Dr Miranda Payne is a Consultant in Medical Oncology, specialising exclusively in the systemic treatment of skin cancers, with particular expertise in the systemic treatment of melanoma and cutaneous squamous cell carcinoma.  Miranda took a first in Physiology from the University of Oxford before completing her clinical training in 1999. In 2006 Miranda was awarded a Cancer Research UK Clinical Fellowship, spending four years researching DNA repair mechanisms at the Weatherall Institute of Molecular Medicine, leading to a DPhil in Medical Oncology, awarded by the University of Oxford. Specialist training was also completed in Oxford, where Miranda recently completed a three-year term as Clinical Lead for the Oncology Department at the Oxford University Hospitals NHS Foundation Trust. Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda’s NHS clinical practice, reflected in her publication record. She has a particular interest in the consequences of immunotherapy and in the management of mucosal melanoma. Miranda is the Thames Valley Training Programme Director for Medical Oncology, is the Thames Valley and South Midlands Skin Cancer Research Lead, was an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published national UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) leading on their recently published Patient Guide, and has been an editor of the Oxford Handbook of Oncology for almost 20 years.

Systemic treatment of melanoma (skin and mucosal) Adjuvant treatment of resected melanoma. Treatment of metastatic melanoma. Systemic treatment of cutaneous squamous cell carcinoma and metastatic basal cell carcinoma.